Evidence map›Paper›PMID 42903450›Full record

ArticleEnvironment & health (Washington, D.C.)2026

Chemical-Specific Metabolic Disruption during Early Zebrafish Development is Modulated by the Microbiome.

Nanna Fyhrquist, Lydia Gugescu, Emma Wincent, Harri Alenius

Abstract read
In one paragraph

Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nanna FyhrquistInstitute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden.
Lydia GugescuInstitute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden.
Emma WincentInstitute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden.
Harri AleniusInstitute of Environmental Medicine, Karolinska Institutet, Stockholm 171 77, Sweden.ORCID https://orcid.org/0000-0003-0106-8923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental contaminants such as per- and polyfluoroalkyl substances, bisphenols, and agricultural fungicides are increasingly recognized as metabolic disruptors, yet how individual chemicals perturb metabolic pathways during early development remains incompletely understood. Here, we used targeted and untargeted metabolomics and pathway analysis in zebrafish embryos to characterize metabolic disruption induced by perfluorooctanesulfonic acid (PFOS), boscalid (BOS), and bisphenol F (BPF). Each compound elicited a distinct metabolic fingerprint, indicating chemical-specific patterns of metabolic stress rather than a uniform response across toxicants. Comparative analysis demonstrated divergence in central metabolic pathways, including mitochondrial metabolism, amino acid and nucleotide turnover, redox balance, and tryptophan metabolism. PFOS induced the most extensive metabolic perturbation, whereas BOS and BPF produced more restricted but distinct metabolic profiles. Comparison of germ-free and conventionally colonized embryos showed that host microbial status modulated the magnitude, but not the direction, of chemical-induced metabolic changes. These metabolic alterations align with exposure-specific transcriptional network modules, supporting distinct chemical modes of action. Together, these findings demonstrate that early life exposure to PFOS, BOS, and BPF results in chemically distinct metabolic stress phenotypes during development and illustrate how integrated metabolomic profiling can resolve compound-specific metabolic effects while accounting for contextual modifiers such as host microbial status.

Indexed as

environmental toxicologygerm-free zebrafishmetabolomicsmicrobiome–toxicant interactionsmode of actionmultiomicszebrafish embryos

Identifiers

PMID42903450
PMCPMC13681445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.